Darcy Krueger
Organisation
Trials
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Phase 2, Recruiting, 2021, 64 people, 3 Nov 2021, clinicaltrials.gov
Organisation
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Phase 2, Recruiting, 2021, 64 people, 3 Nov 2021, clinicaltrials.gov